Page last updated: 2024-10-27

fluoxetine and Akinetic Autism

fluoxetine has been researched along with Akinetic Autism in 1 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Conway, A1

Other Studies

1 other study available for fluoxetine and Akinetic Autism

ArticleYear
Difficulties in managing a case of stupor.
    The British journal of psychiatry : the journal of mental science, 1993, Volume: 162

    Topics: Adult; Akinetic Mutism; Combined Modality Therapy; Consciousness Disorders; Droperidol; Female; Fluo

1993